GJCU yields 666.67% · PFE yields 6.13%● Live data
📍 GJCU pulled ahead of the other in Year 1
Combined, GJCU + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GJCU + PFE for your $10,000?
GJ Culture Group US, Inc. provides educational and other related services based on classical Chinese studies and culture. The company offers international study tours, which include the youth study tour series, adult study tour series, and themed study tour series of culture and art. It also provides lectures on classical studies; meditation courses; education and training services; and cultural events and art exhibitions. In addition, the company offers consulting and planning services to its contracted Chinese partners, including telephone or online consultation regarding market and research analysis of classical Chinese culture study in the United States for the business activities or international tour proposed by its Chinese partners, as well as online oral trainings to the staff of its Chinese business partners. It serves the Chinese-Americans, American youths, scholars, art collectors, and professional and corporate executives interested in learning about Chinese culture. The company was formerly known as Guojiang Cultural Industry US, Inc. and changed its name to GJ Culture Group US, Inc. in February 2019. GJ Culture Group US, Inc. was incorporated in 2018 and is based in Danville, California.
Full GJCU Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.